1. Home
  2. HZO vs ESPR Comparison

HZO vs ESPR Comparison

Compare HZO & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

HOLD

Current Price

$34.70

Market Cap

769.2M

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.14

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HZO
ESPR
Founded
1998
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
769.2M
731.9M
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
HZO
ESPR
Price
$34.70
$3.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$30.00
$8.75
AVG Volume (30 Days)
384.6K
12.0M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
$2,309,288,000.00
$403,135,000.00
Revenue This Year
$3.67
N/A
Revenue Next Year
$4.01
$12.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.31
52 Week Low
$21.39
$0.95
52 Week High
$36.25
$4.18

Technical Indicators

Market Signals
Indicator
HZO
ESPR
Relative Strength Index (RSI) 60.95 70.78
Support Level $24.00 $3.11
Resistance Level $36.25 $3.18
Average True Range (ATR) 1.46 0.01
MACD -0.03 -0.02
Stochastic Oscillator 69.49 100.00

Price Performance

Historical Comparison
HZO
ESPR

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: